A Peek Into The Markets: U.S. Stock Futures Climb Ahead Of Economic Data
U.S. stock futures traded higher in early pre-market trade. Data on initial jobless claims for the recent week, retail sales for August the Producer Price Index for August, the Philadelphia Fed general conditions index for September, the Empire State manufacturing index for September and the current account report for the second quarter will be released at 8:30 a.m. ET. Data on industrial production for August will be released at 9:15 a.m. ET, while data on business inventories for July will be released at 10:00 a.m. ET.
Futures for the Dow Jones Industrial Average rose 73 points to 17,993.00, while the Standard & Poor’s 500 index futures gained 8.75 points to 2,122.00. Futures for the Nasdaq 100 index rose 18 points to 4,746.75.
Oil prices traded higher as Brent crude futures rose 1.26 percent to trade at $46.43 per barrel, while US WTI crude futures also rose 1.02 percent to trade at $44.60 a barrel. The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
A Peek Into Global Markets
European markets were higher today, with the Spanish Ibex Index rising 0.30 percent, STOXX Europe 600 Index gaining 0.31 percent and German DAX 30 index gaining 0.27 percent. The UK's FTSE index was trading higher by 0.24 percent, while French CAC 40 Index rose 0.05 percent. The eurozone's trade surplus narrowed to 20 billion euros ($22.5 billion) in July, versis EUR23.8 billion in June. U.K. retail sales declined 0.2 percent in August from July.
In Asian markets, Japan’s Nikkei Stock Average fell 1.26 percent, Hong Kong’s Hang Seng Index rose 0.63 percent, China’s Shanghai Composite Index declined 0.68 percent and India’s BSE Sensex rose 0.14 percent.
Analysts at Oppenheimer upgraded Dicks Sporting Goods Inc (NYSE: DKS) from Market Perform to Outperform.
Dick's Sporting shares rose 0.78 percent to $59.11 in pre-market trading.
- Aerie Pharmaceuticals Inc (NASDAQ: AERI) surged more than 58 percent in pre-market trading on news about its Phase 3 study of Roclatan having met its primary efficacy endpoint. To read the full news, click here.
- Apogee Enterprises Inc (NASDAQ: APOG) reported better-than-expected Q2 results and boosted its fiscal 2017 outlook.
- Student Transportation Inc (NASDAQ: STB) posted stronger-than-expected results for its fourth quarter on Wednesday.
- AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) disclosed that its investigational product candidate ARX-04 provided solid tolerance level in an open-label Phase three trial for post operative acute pain treatment. This included elderly patients, as well as, organ impairment. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.